Midodrine HCl API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Midodrine HCl API

Midodrine Hydrochloride is an orally active sympathomimetic agent and alpha-adrenergic agonist used primarily for the management of symptomatic orthostatic hypotension. It is a prodrug that is converted to its active metabolite, desglymidodrine, which produces peripheral vasoconstriction and increases vascular tone.

Midodrine HCl is an important cardiovascular pharmaceutical API used in the manufacture of oral medicines for blood-pressure support.

Midodrine HCl API Manufacturer in India

Midodrine Hydrochloride is a specialized vasopressor / cardiovascular API requiring controlled manufacturing and analytical testing. Quality evaluation typically focuses on assay, identification, related substances, water content, residual solvents and other applicable pharmaceutical quality attributes.

Chemical Information

CAS Number: 3092-17-9
Molecular Formula: C12H18N2O4·HCl
Molecular Formula as salt: C12H19ClN2O4
Molecular Weight: 290.74 g/mol
Chemical Name: 2-Amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide monohydrochloride
Synonyms: Midodrine Hydrochloride, Midodrine HCl
Drug Class: Sympathomimetic / Alpha-Adrenergic Agonist
Therapeutic Class: Vasopressor / Antihypotensive Agent
Therapeutic Area: Cardiovascular
Primary Application: Orthostatic Hypotension

USP identifies Midodrine Hydrochloride as C12H18N2O4·HCl, molecular weight 290.74, with an assay range of 98.0–102.0% on the anhydrous basis.

Mechanism of Action

Midodrine is converted to desglymidodrine, its pharmacologically active metabolite. Desglymidodrine acts as a selective alpha-adrenergic receptor agonist, producing peripheral vasoconstriction and increasing vascular resistance.

This results in:

  • Increased peripheral vascular tone
  • Increased venous and arterial resistance
  • Increased blood pressure
  • Reduction of symptoms associated with orthostatic hypotension

Pharmaceutical Applications

Midodrine HCl API is primarily associated with:

  • Symptomatic orthostatic hypotension
  • Blood-pressure support
  • Cardiovascular pharmacology
  • Autonomic dysfunction research
  • Vasopressor drug development

The FDA chemistry documentation identifies Midodrine HCl as a blood-pressure medication used for orthostatic hypotension.

Dosage Form Applications

Midodrine Hydrochloride is primarily formulated as:

  • Immediate-release tablets
  • Oral solid dosage forms

FDA documentation lists tablet strengths of 2.5 mg, 5 mg and 10 mg.

Physical and Chemical Properties

Midodrine Hydrochloride is described as an odorless, white crystalline powder. It is soluble in water and sparingly soluble in methanol. Its reported pKa is 7.8, pH is 3.5–5.5 for a 5% aqueous solution, and melting range is 200–203°C.

Manufacturing Process

A controlled Midodrine HCl API manufacturing process may include:

  1. Qualification of starting materials
  2. Preparation of substituted aromatic intermediates
  3. Formation of the amino-alcohol intermediate
  4. Controlled amide formation
  5. Purification
  6. Hydrochloride salt formation
  7. Crystallization
  8. Filtration
  9. Controlled drying
  10. Final analytical testing
  11. Pharmaceutical-grade packaging

Quality Control Testing

Important analytical tests include:

  • Identification by IR
  • HPLC identification
  • Assay
  • Related substances
  • Water content
  • Loss on drying
  • Residual solvents
  • Elemental impurities
  • pH
  • Specific rotation where applicable
  • Melting range
  • Stability testing

Detailed Specifications

Parameter Specification
Appearance White crystalline powder or crystals
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 1.0%
Residue on Ignition NMT 0.5%
pH (1% Solution) 3.5–5.5
Individual Impurity NMT 0.5%
Total Impurities NMT 1.0%
Water Content NMT 1.0%
Melting Point 200–203°C
Get Bulk Quote via WhatsApp